These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 30208847

  • 1. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
    Eisenga MF, Nolte IM, van der Meer P, Bakker SJL, Gaillard CAJM.
    BMC Nephrol; 2018 Sep 12; 19(1):225. PubMed ID: 30208847
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
    Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD.
    Nephrol Dial Transplant; 2021 Jan 01; 36(1):129-136. PubMed ID: 31641775
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria.
    Raji YR, Ajayi SO, Akingbola TS, Adebiyi OA, Adedapo KS, Salako BL.
    Niger Postgrad Med J; 2018 Jan 01; 25(4):197-203. PubMed ID: 30588939
    [Abstract] [Full Text] [Related]

  • 9. Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial.
    Womack R, Berru F, Panwar B, Gutiérrez OM.
    Clin J Am Soc Nephrol; 2020 Sep 07; 15(9):1251-1258. PubMed ID: 32694162
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
    Prats M, Font R, García C, Muñoz-Cortés M, Cabré C, Jariod M, Romeu M, Giralt M, Martinez-Vea A.
    Clin Nephrol; 2014 Jun 07; 81(6):419-26. PubMed ID: 24691014
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A 3-marker index improves the identification of iron disorders in CKD anaemia.
    Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Stengel B, NephroTest Study Group.
    PLoS One; 2014 Jun 07; 9(2):e84144. PubMed ID: 24586229
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of iron status in predialysis chronic kidney disease patients in a Nigerian Tertiary Hospital.
    Iyawe IO, Adejumo OA, Iyawe LI, Oviasu EO.
    Saudi J Kidney Dis Transpl; 2018 Jun 07; 29(6):1431-1440. PubMed ID: 30588977
    [Abstract] [Full Text] [Related]

  • 17. Ferrokinetics is associated with the left ventricular mass index in patients with chronic kidney disease.
    Tanaka A, Inaguma D, Watanabe Y, Ito E, Kamegai N, Shimogushi H, Shinjo H, Koike K, Otsuka Y, Takeda A.
    Acta Cardiol; 2017 Aug 07; 72(4):460-466. PubMed ID: 28705055
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.